Most of this sialylated protein is secreted from skeletal muscle, heart, and adipose tissue when proteinuria reaches nephrotic range in an attempt to reduce proteinuria through glomerular endothelial binding; it induces also hypertriglyceridemia via inhibition of lipoprotein lipase (LPL). Here, LPL is linked to hypertriglyceridemia.